TAMPA - Sypris Electronics, LLC, a subsidiary of Sypris Solutions, Inc. (NASDAQ:SYPR), has received a follow-on contract to manufacture and test electronic power supply modules for a classified ...

CORVALLIS, Ore., September 03, 2025--(BUSINESS WIRE)--NuScale Power Corporation (NYSE: SMR), the industry-leading provider of proprietary and innovative advanced small modular reactor (SMR) nuclear ...

Agencies appear to be making unauthorized payments on a large scale. Federal spending law prohibits agencies from using funds without congressional authorization. But under the Fork in the Road ...

The federal government is looking for researchers who can, in 5 years, develop stem cell treatments to repair brain damage caused by stroke, neurodegeneration, and trauma. The Functional Repair of ...

WASHINGTON (DC News Now) — A coding franchise is getting young kids ready for the future by adding artificial intelligence and more to its coding program. At Code Ninjas, it’s all about bringing fun ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Good programmers need to create code that efficiently solves problems, using various methods. A ...

The head of Portland’s economic development agency Thursday blasted a proposal by two City Council members for cuts he said would “decimate” Prosper Portland’s long-term program funding. In an email ...

Abstract: Current state-of-the-art plug-and-play countermeasures for mitigating adversarial examples (i.e., purification and detection) exhibit several fatal limitations, impeding their deployment in ...

New York –Town & Country Living is expanding its pet products program with a new collection of accessories that tout comfort, style and easy care. Designed to complement modern home décor trends, the ...

As a first-stop entertainment destination, Prime Video is home to a vast selection of movies and series—but language barriers can prevent customers from enjoying content originating from countries and ...

TIXiMED is developing TIX100, a proprietary non-immunosuppressive therapy that may become the first oral disease-modifying treatment option for people with type 1 diabetes The first-in-human, single ...